Ligand validation:4DVW

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 4DVW designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Model completeness	Average occupancy
4DVW_NAG_A_503	91%	65%	0.087	0.973	0.51	0.81	-	-	1	100%	0.9333
4DVW_NAG_A_504	81%	69%	0.094	0.946	0.53	0.65	-	-	1	100%	0.9333
4DVW_NAG_A_505	74%	66%	0.101	0.931	0.53	0.76	-	-	0	100%	0.9333
4DVW_NAG_A_501	69%	67%	0.127	0.942	0.52	0.74	-	-	0	100%	0.9333
4DVW_NAG_A_509	68%	70%	0.116	0.928	0.54	0.62	-	-	0	100%	0.9333
4DVW_NAG_A_508	66%	64%	0.122	0.927	0.67	0.7	-	-	1	100%	0.9333
4DVW_NAG_B_503	61%	69%	0.145	0.958	0.52	0.67	-	-	0	87%	0.8667
4DVW_NAG_B_505	55%	71%	0.119	0.888	0.53	0.6	-	-	0	100%	0.9333
4DVW_NAG_B_509	54%	69%	0.11	0.875	0.52	0.68	-	-	1	100%	0.9333
4DVW_NAG_B_506	49%	69%	0.144	0.891	0.55	0.63	-	-	0	100%	0.9333
4DVW_NAG_B_501	39%	70%	0.215	0.921	0.55	0.6	-	-	0	100%	0.9333
4DVW_NAG_A_506	32%	68%	0.217	0.889	0.57	0.66	-	-	0	100%	0.9333
4DVW_NAG_A_507	13%	68%	0.309	0.857	0.54	0.7	-	-	2	100%	0.9333
4DVW_NAG_A_510	5%	66%	0.236	0.652	0.51	0.79	-	-	2	100%	0.9333
4DVW_NAG_B_510	5%	70%	0.307	0.718	0.53	0.63	-	-	1	100%	0.9333
4DVW_NAG_B_504	5%	69%	0.353	0.756	0.53	0.66	-	-	0	100%	0.9333
4DVW_NAG_B_507	5%	67%	0.327	0.723	0.54	0.73	-	-	0	100%	0.9333
4DVW_NAG_B_508	1%	69%	0.61	0.718	0.56	0.62	-	-	0	100%	0.9333
4DVW_NAG_A_502	0%	70%	0.633	0.593	0.52	0.65	-	-	1	100%	0.9333
4DVW_NAG_B_502	0%	70%	1.046	0.483	0.53	0.62	-	-	0	100%	0.9333
4YFL_NAG_E_507	98%	70%	0.061	0.985	0.48	0.66	-	-	0	100%	0.9333
3SE8_NAG_G_734	94%	68%	0.063	0.961	0.56	0.68	-	-	0	100%	0.9333
4LSQ_NAG_G_503	93%	57%	0.065	0.96	0.58	1.07	-	1	0	100%	0.9333
7SX7_NAG_A_508	92%	71%	0.073	0.964	0.28	0.84	-	1	0	100%	0.9333
4LSR_NAG_G_502	90%	62%	0.08	0.964	0.61	0.85	-	-	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	100%	0.9333
3GXM_NAG_A_498	100%	45%	0.026	0.992	0.75	1.34	-	2	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.

Prepare Data

Validate Data

Deposit Data

Help and Resources

4DVW

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 4DVW designated by the RCSB